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SUMMARY Adhesion molecules may play an important role in 
the homing of T-cell subsets into allergen-exposed skin of atopic 
individuals. The aim of this pilot study was to examine the expression 
of adhesion molecules in atopic dermatitis (AD) skin lesions. 
Biopsies were taken at acute skin lesions from 10 AD patients and 
5 healthy controls, and were studied by immunohistocytochemistry 
for the expression of E-selectin, L-selectin, ICAM-1 and ICAM-3 
on cells in the epidermis and dermis. Study results revealed all 
AD patients to express ICAM-1 (10/10) and ICAM-3 (10/10) in 
the dermis, and most of them to express E-selectin (9/10) and 
L-selectin (6/10) in the dermis, without expression of E- and L-
selectins in the epidermis. Our results revealed a high expression 
of adhesion molecules, especially ICAM-1 and ICAM-3, in the 
skin lesions of AD patients, which may play an important role in 
the pathogenesis of AD, and these preliminary results may be of 
clinical relevance for the treatment of AD.
KEY WORDS: atopic dermatitis, skin, adhesion molecules, 
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INTRODUCTION
 Atopic dermatitis (AD) is a chronic relapsing 
inﬂammatory skin disorder associated with erythe-
ma, scaly and oozing plaques on the forehead and 
face, which spread to the neck, hands and ﬂexural 
areas, and severe pruritus (1-5). AD is character-
ized by the predominant inﬁltration of T cells, eo-
sinophils and macrophages in the lesional skin. It 
appears that immediate, late and delayed allergic 
reactions are invovled. Since immune dysregula-
tion is a possible key defect in AD, the expression 
of different immunologic parameters and costimu-
latory molecules such as integrins and selectins 
have been studied in AD patients (6). Adhesion mol-
ecules E-selectin, P-selectin, ICAM-1 and VCAM-
3 are membrane-bound molecules that mediate 
the attachment of leukocytes to endothelial cells 
and are preferentially expressed on activated en-
dothelium (7,8). The selectin family of membrane 
glycoproteins are responsible for the initial sticki-
ness of leukocytes to vascular endothelium and 
include three molecules designated as L, E and P. 
It has been observed that most circulating leuko-
cytes express L-selectin, whereas E-selectin and 
P-selectin are expressed on vascular endothelial 
cells (8). Analysis of AD skin for the expression 
of VCAM-1, ICAM-1, E-selectin and P-selectin on 
endothelium showed a signiﬁcantly higher VCAM-
1 expression in erythrodermic AD than in lesional 
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skin of AD, without differences in the expression 
of other adhesion molecules. In atopic diseases L-
selectin is involved in the extravasation of mono-
cytes towards local inﬂammatory sites, and high 
serum sL-selectin level in children suggested its 
presence in the pathogenesis of the disease (9).
 PATIENTS AND METHODS
 Only patients with clear clinical signs of AD 
were included in the study. The diagnosis of AD 
was made by using the criteria of Haniﬁn and Ra-
jka (10). The patients received no treatment for 
at least one week before the study. Biopsy speci-
mens were obtained from acute skin lesions of ten 
AD patients (three females and seven males). The 
patients were aged 25-50 (mean age 34) years. 
Skin specimens from ten healthy age-matched do-
nors, stained with the same antibodies were used 
as control samples. 
 Skin biopsies were immunohistochemically 
stained with anti-ICAM-1, ICAM-3, E-selectin and 
L-selectin antibody (Dako, Glostrup, Denmark). 
Slides were stained in an automated immunostain-
er (TechMate, Dako) using standard avidin-biotin 
immunoperoxidase staining method. The immu-
nohistochemically stained slides were analyzed 
by using light microscope. In the skin lesions of 
AD patients the expression of adhesion molecules 
(ICAM-1, ICAM-3, E-selectin and L-selectin) in the 
dermis and epidermis was analyzed semiquantita-
tively. Total cell count per mm2 of dermis and total 
cell count per mm epidermis length were deter-
mined. 
RESULTS
 The results obtained from AD patients in com-
parison to healthy controls yielded a greater ex-
pression of adhesion molecules in AD skin lesions 
than in healthy controls (Fig. 1). Study results 
showed the majority of AD patients to express 
adhesion molecules (ICAM-1, ICAM-3, E-selectin 
and L-selectin) in the dermis of skin lesions (Figs. 
1 and 2). ICAM-1 was expressed in the epidermis 
of six AD patients (high in two and moderate in 
four patients), but all patients expressed ICAM-1 
in the dermis (high in four and moderate in six pa-
tients). ICAM-3 was moderately expressed in the 
epidermis of six AD patients, but all AD patients 
expressed ICAM-3 in the dermis (high in four and 
moderate in six patients). E-selectin in the dermis 
was expressed in nine patients (moderate in ﬁve 
and rare in four patients), whereas the expression 
of E-selectin in the epidermis was not observed.  
 The expression of L-selectin in the dermis was 
moderate in six patients, whereas another four 
patients did not express it. The expression of E-
selectin and L-selectin was not observed in the 
epidermis of AD patients. 
 The expression of ICAM-1, ICAM-3, E-selectin 
and L-selectin adhesion molecules was not ob-
served in the skin of healthy controls.
 Study results revealed the majority of AD pa-
tients to express adhesion molecules (ICAM-1, 
ICAM-3, E-selectin and L-selectin)  in their skin le-
sions. 
DISCUSSION
 Various studies have indicated the importance 
of cell adhesion molecules (CAMs) and their sol-
uble forms (sCAMs) in the interactions between 
vascular endothelium and activated leukocytes in 
various inﬂammatory skin diseases including AD 
(6,11). It has been observed that selectins and 
CAMs such as E-selectin, P-selectin, ICAM-1 and 
VCAM-1 are preferentially expressed on activated 
endothelium mediating attachment of leukocytes 
to endothelial cells, and expression of selectins 
(E-selectin, L-selectin and P-selectin), vascular 
Figure 1. Skin specimen of atopic dermatitis 
immunohistochemically stained with anti-VCAM 
antibody, showing strong intensity staining on 
vascular endothelial cells in the dermis and on 
some leukocytes in the dermis and epidermis. 
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and intercellular adhesion molecules, cutaneous 
lymphocyte antigen (CLA) have been examined 
in AD skin. Comparison of the skin of normal and 
atopic individuals for the expression of E-selec-
tin (ELAM-1), L-selectin (LECAM-1), P-selectin 
(CD62), CD31 (PECAM), VCAM-1 and ICAM-
1 showed a signiﬁcantly increased expression 
of VCAM-1 and ICAM-1 (in contrast to ELAM-1) 
in nonlesional atopic skin as compared with the 
skin of healthy controls (12). These data revealed 
constitutive upregulation of certain adhesion mol-
ecules in healthy-appearing skin of AD patients, 
mediated by the release of cytokines such as 
interleukin-4 (IL-4) from Th2-cells that reside in 
atopic skin. 
 Our study results, similar to those reported by 
Jung et al., also conﬁrmed a greater expression 
of adhesion molecules in AD skin lesions than in 
the skin of healthy controls, revealing expression 
of ICAM-1, ICAM-3, E-selectin and L-selectin in 
the dermis of skin lesions of the majority of AD 
patients (12). Most prominent was the expres-
sion of ICAM-1 and ICAM-3 in the dermis of all 
AD patients, and of E-selectin in the dermis of the 
majority of them. The expression of L-selectin in 
the dermis was found in about half of AD patients, 
without expression of E-selectin and L-selectin in 
the epidermis of these patients. The expression of 
adhesion molecules (ICAM-1, ICAM-3, E-selectin 
and L-selectin) in the skin lesions of the majority of 
AD patients supports their role in cell interactions. 
However, another examination of E-selectin, P-se-
lectin, CD31, VCAM-1 and ICAM-1 on endothelial 
and other skin cells revealed no major differences 
between various types of skin reactions in atopics, 
nor did the skin of AD patients differ from that of 
healthy controls (13). 
 Besides the role of membrane-bound mole-
cules, the soluble forms of CAMs (sCAMs) have 
also been detected in the sera of AD patients, re-
sulting from shedding, and some may reﬂect AD 
activity (7). In severe AD patients markedly el-
evated levels of E-selectin were found, VCAM-1, 
and ICAM-1, and signiﬁcantly elevated sE-selectin 
in severe AD over the levels in mild AD (11). The 
levels of sE-selectin also showed positive correla-
tion with sVCAM-1 levels, serum IgE levels and 
eosinophil number, thus being a sensitive clinical 
parameter in monitoring the clinical course in AD 
patients (11). A study including children with AD 
showed a signiﬁcantly increased sE-selectin in 
children with speciﬁc IgE and correlation with AD 
activity, also conﬁrming their use in monitoring the 
disease activity (7).
 Examination of the roles of E- and P-selectin 
in eosinophil recruitment in inﬂamed AD skin, and 
the expression of sialyl-Lewis x (sLex) structures 
and selectin ligands on eosinophils revealed blood 
eosinophils bound to sP-selectin, however, eosino-
phils had little avidity for sE-selectin (14). A signiﬁ-
cantly greater amount of P-selectin bound to eosin-
ophils was observed in AD patients than in healthy 
controls, indicating eosinophil interaction with en-
dothelial P-selectin, important for recruitment into 
the inﬂamed AD skin (14). Several laboratory mark-
ers including sCAMs and eosinophil granular pro-
teins have been described to correlate positively 
with the disease activity of AD, but the assessment 
of different objective and subjective parameters (E-
selectin, sVCAM-1) revealed that only sE-selectin 
and subjective parameters statistically signiﬁcantly 
correlated with the Scoring AD (SCORAD) score 
(15). We found E-selectin in the dermis of almost 
all AD patients, and L-selectin in the dermis of 
about half of the patients, without E-selectin and 
L-selectin expression in the epidermis.
 ICAMs are involved in AD pathogenesis, includ-
ing repeated antigen stimulation and contact hy-
persensitivity responses, which cause chronic in-
ﬂammatory responses with inﬁltrating leukocytes. 
A study in mice has revealed that L-selectin and 
Figure 2. L-selectin expression on some leukocytes 
in the dermis of a patient with atopic dermatitis. 
Immunohistochemistry with anti-L-selectin anti-
body, counterstaining with hematoxylin, x400.
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ICAM-1 cooperatively regulate the induction of im-
mediate-type response by mediating mast cell ac-
cumulation into inﬂammatory sites, with a potential 
use as targets for regulating human allergic reac-
tions (16). Migration of cells into the skin lesions is 
connected with skin-homing receptor CLA, a car-
bohydrate epitope expressed on memory/effector 
T cells, which inﬁltrate inﬂamed skin, mostly aller-
gen-speciﬁc Th2 cells that generate exacerbated 
responses and induce skin inﬂammation (17). 
Namely, naive Th cells with receptors for cutaneous 
antigens become activated in skin-draining lymph 
nodes and express CLA, confering the capacity to 
migrate into the skin. E-selectin is a ligand for CLA, 
which is induced under inﬂammation on endothe-
lial cells, and targeting CLA/E-selectin interactions 
prevents recruitment of Th2 memory cells to the 
skin, which can be efﬁciently suppressed by using 
a low molecular weight E-selectin antagonist that 
may be of clinical relevance for the treatment of 
AD (Fig. 3). This selective transendothelial migra-
tion of memory/effector T cells by interaction with 
E-selectin on endothelial cell layers involves acti-
vation of proinﬂammatory cytokines and receptor-
ligand pairs VLA-4/VCAM-1 and LFA-1/ICAM-1 
(18). Our previous study has conﬁrmed that AD 
skin lesions are predominantly inﬁltrated by CD3+ 
with high expression of CD45Ro (memory T cells), 
CD1a, CD29, IFNγ+cells, as supported by other 
authors (5). Analysis of CD45RO+ T cells of AD 
patients and speciﬁc in vitro response to skin-as-
sociated allergens has revealed enhanced migra-
tion of CLA+ T cells through activated human um-
bilical vein endothelial cell monolayers compared 
to CLA- T cells. The CLA binding to E-selectin is 
initially responsible for the extravasation that also 
involves VLA-4/VCAM-1 and LFA-1/ICAM-1 inter-
actions (18). Migration of CLA+ T cell is connected 
with IL-8 as an endothelial cell-derived chemokine 
and is under the control of IL-8 receptor type B, 
which localizes memory/effector T cells that re-
spond to antigens and reach the body through in-
ﬂamed skin (18). This regionalization of the skin 
immune system may allow for an efﬁcient distri-
bution of immune defense to different sites of the 
body. On the other hand, the examination of cord 
blood T cells in infants with AD stimulated by milk 
allergen has shown that the gut-homing receptor 
integrin alphaEbeta7 but not CLA precedes the 
development of milk-induced eczema in early in-
fancy, providing a clue to the avoidance of speciﬁc 
allergens and potential therapy targeting homing 
receptors in food allergy (19).
 It is also important that adhesion, chemotaxis, 
and activation of many types of leukocytes are 
under the control of various chemokines such 
as CCR3/CCR4 and CCR5/CXCR3, expressed 
on the inﬁltrating Th2-cells in skin lesions. Che-
mokines are a superfamily of small polypeptides, 
which selectively and often speciﬁcally control the 
adhesion, chemotaxis and activation of leukocytes, 
which are separated, based on the position of the 
four invariant cysteine residue, into C-C subgroup 
and C-X-C subgroup (7). It has been observed that 
IL-8 and related Glu-Leu-Arg (ELR+) CXC chemo-
kines are potent chemoattractants for neutrophils 
and accumulation and positioning of mononuclear 
phagocytes in Th2-dominated responses (19). 
Examination of peripheral blood from AD patients 
has shown a signiﬁcantly higher percentage of 
CCR4+ cells in CD4+ CD45RO+ T cells than in 
healthy controls, which correlated positively with 
total serum IgE, eruption score, eosinophil num-
ber, lactate dehydrogenase (LDH), IL-4 and IL-13 
secretion in CD4+ T cells, and inversely with IL-2 
and IFNγ secretion in CD4+ T cells (20). AD pa-
tients had a signiﬁcantly decreased percentage 
of CCR5+ or CXCR3+ cells in CD4+ CD45RO+ T 
cells, which correlated positively with the eruption 
score, without detection of CCR3 on circulating 
CD4+ T cells in AD patients (21).
 Two CC chemokines have also been identiﬁed: 
macrophage-derived chemokine (MDC)/CCL22, 
a selective chemoattractant for CCR4-express-
ing cells, and thymus and activation-regulated 
chemokine (TARC), its serum levels correlating 
with AD severity (3). Serum MDC levels signiﬁ-
cantly correlated with the SCORAD index, serum 
sE-selectin, sIL-2Rs, TARC and eosinophils (3). 
Figure 3. A scheme of cell interactions in cell 
adhesion to the endothelium in atopic dermatitis 
skin (modiﬁed from Goldsby RA, Kindt TJ, 
Osborne AO) (8).
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Important roles of some other adhesion molecules 
have also been noticed on various cells such as 
dendritic cells (DC) and Langerhans cells (LCs), 
and homing receptors for T cells that are selective 
for skin localizations (22). It is important not to for-
get various molecules expressed on LCs such as 
E-cadherin, a homophilic adhesion molecule, etc.
CONCLUSION
 Our results revealed the expression of ICAM-1 
and ICAM-3 in the dermis of all AD patients, and 
expression of E-selectin and L-selectin in the der-
mis of most of them, which may be the result of 
enhanced cell activation and migration to skin le-
sions. Although many new information regarding 
the pathogenesis of AD have evolved over the 
past several years, the basic underlying etiology 
of this disorder remains elusive. We hope that the 
coming years will witness the development of new 
strategies for the treatment of AD, aimed at spe-
ciﬁc targets based on a thorough understanding of 
its pathogenesis.
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